As a clinical and translational science investigator, Dr. Henry Huang's work has centered on developing innovative therapeutic approaches to overcome limitations in current ventricular and atrial arrhythmia ablation strategies and elucidating mechanistic links and treatment of autonomic nervous system-related arrhythmias. A particular area of expertise he has is in the biophysics of ablation, where over the past five years he has focused on understanding the constraints of thermal radiofrequency (RF) ablation across various cardiac tissue substrates and optimizing operator-determined parameters to enhance lesion quality.
Dr. Huang developed a novel preclinical technique employing infrared thermography to characterize thermal dynamics during ablation. This work yielded clinically translatable insights into the heating patterns associated with RF energy delivery. Building on these findings and other studies, Dr. Huang led the design and implementation of the world’s first randomized controlled trial focused on ablation biophysics. This study compares an "Ablation Index (a multiparametric lesion quality marker) to traditional operator-determined RF application durations in scar-mediated ventricular tachycardia (VT) ablation. Given the current lack of a standardized metric for lesion quality, we hypothesized that an Ablation Index-guided strategy will improve procedural efficiency and safety.
To address another major clinical challenge involving the treatment of deep arrhythmic substrates inaccessible to conventional RF catheter technologies, Dr. Huang spearheaded the development of a novel toroidal-shaped catheter. This Focused Electric Field (FEF) catheter overcomes surface-dependent resistive heating limitations inherent to solid-tip catheters. Using infrared thermography, we demonstrated that the toroidal catheter achieves a collimated energy field and uniform temperature distribution, resulting in significantly larger lesions than conventional ablation catheters in ex-vivo and in-vivo porcine models.
More recently, Dr. Huang's lab has extended this work into the realm of non-thermal energy sources for ablation with investigations in the use of Pulsed Field Ablation (PFA) in several catheter forms, including the development of the FEF catheter for this form of energy delivery. Additionally, Dr. Huang was actively involved in the design and testing of a novel endoscopic balloon-based PFA system.
Another key area of his research focuses on autonomic modulation for arrhythmia therapy, particularly in patients with cardioinhibitory vasovagal syncope. As this patient population tends to be younger and without structural heart disease treatment alternatives to permanent pacemaker implantation are desired. Currently
Dr. Huang is leading the first prospective registry with cross-over design (CNA-FWRD) which will include over 40 international participating centers. He recently presented the first multicenter clinical study (PIRE-CNA) evaluating CNA in patients with vagally mediated atrioventricular block.
Dr. Huang has also served as Editor-in-Chief of the Journal of Interventional Cardiac Electrophysiology. In his last 4 years in his role as the editor, the journal's Impact Factor has increased and reach in the field has increased significantly placing it amongst the top 5 journals in the field of cardiac electrophysiology.